Lyka Labs
Company Overview - January 14, 2025
Lyka Labs is a notable player in the Pharmaceuticals - Indian - Bulk Drugs & Formln industry, listed on both the BSE (Code: 500259) and NSE (Code: LYKALABS). As of the January 14, 2025, the company holds a market capitalization of INR 556.24 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 155.85, Lyka Labs has demonstrated a 17.33% return over the last year. Recent performance indicates fluctuations, with a 9.18% change in the past week and a 9.59% change over the last month. The company's all-time high stands at INR 267.20, while its lowest-ever price was INR 8.15.
In terms of sales, Lyka Labs reported a revenue of INR 131.60 crores, solidifying its position in the market. The average trading volume over the past month has been 144545 shares, with a more recent weekly average of 189683.
With the stock trading above its 50-day moving average of INR 144.42, the company's technical indicators like MACD (1.86) signal positive trends.
Company Data
| Name | Lyka Labs |
|---|---|
| BSE Code | 500259 |
| NSE Code | LYKALABS |
| Industry | Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Current Price | 155.85 |
| Market Capitalization | 556.24 |
| Sales | 131.60 |
| Return over 3months | 2.35 |
| Return over 6months | 43.99 |
| Volume 1month average | 144545 |
| Volume 1week average | 189683 |
| Volume | 167689 |
| High price | 172.65 |
| Low price | 97.90 |
| High price all time | 267.20 |
| Low price all time | 8.15 |
| Return over 1day | -0.29 |
| Return over 1week | 9.18 |
| Return over 1month | 9.59 |
| Return over 1year | 17.33 |
| Return over 3years | -1.68 |
| Return over 5years | 56.51 |
| Volume 1year average | 200016 |
| DMA 50 | 144.42 |
| DMA 200 | 131.87 |
| DMA 50 previous day | 143.95 |
| DMA 200 previous day | 131.63 |
| MACD | 1.86 |
| MACD Signal | 0.60 |